School of Medicine and Health Management, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, Hubei, China.
Department of Epidemiology & Health Statistics, School of Public Health, School of Medicine, Zhejiang University, Hangzhou 310058, Zhejiang, China; Office of Graduate Education, School of Medicine, Zhejiang University, Hangzhou 310058, Zhejiang, China.
J Diabetes Complications. 2018 Jul;32(7):635-642. doi: 10.1016/j.jdiacomp.2018.04.008. Epub 2018 Apr 25.
Gestational diabetes mellitus (GDM) and different time-point glucose levels might have different effects on fetal birth weight. The aim of this study was to further evaluate the associations of GDM and different time-point blood glucose levels with fetal birth weight in a prospective cohort study.
This prospective cohort study was conducted in Zhoushan Maternal and Child Health Hospital, Zhejiang, from August 2011 to May 2015. 1232 pairs of singleton, full-term newborns and their mothers without other pregnant and perinatal complications were selected as participants.
Of the 1232 women, 234 had GDM. GDM was positively associated with birth weight (β = 99.5 g, P = 0.0002), gestational age-specific Z-score of birth weight (β = 0.23, P = 0.0003), and an increased risk of large for gestational age (LGA; OR = 1.79, 95%CI: 1.11-2.89) and macrosomia (OR = 2.13, 95%CI: 1.34-3.40). Compared with abnormal fasting plasma glucose (FPG) during the second trimester, abnormal postload glucose in oral glucose tolerance test had significantly higher birth weight and gestational age-specific Z-score of birth weight, and an increased risk of macrosomia. Abnormal FPG and abnormal postload glucose had significantly joint effect on birth weight (β = 161.4 g, P = 0.0192), gestational age-specific Z-score of birth weight (β = 0.42, P = 0.0121) and risk of macrosomia (OR = 3.24, 95%CI: 1.21-8.67) and LGA (OR = 5.73, 95%CI: 2.20-14.90). Compared with abnormal blood glucose during the first trimester, GDM had significantly higher birth weight and gestational age-specific Z-score of birth weight. Abnormal blood glucose during the first trimester and GDM had significantly joint effect on birth weight (β = 125.8 g, P = 0.0010), gestational age-specific Z-score of birth weight (β = 0.30, P = 0.0013) and risk of macrosomia (OR = 2.34, 95%CI: 1.28-4.30) and LGA (OR = 2.53, 95%CI: 1.37-4.67). However, we did not find blood glucose during the first trimester independently associated with birth weight.
GDM was significantly associated with higher birth weight and an increased risk of LGA and macrosomia. Fetal growth was mostly influenced by postload glucose levels, rather than FBG. Moreover, different time-point blood glucose levels had significantly joint effects on birth weight and risk of LGA and macrosomia.
妊娠期糖尿病(GDM)和不同时间点的血糖水平可能对胎儿出生体重有不同的影响。本研究旨在通过前瞻性队列研究进一步评估 GDM 和不同时间点的血糖水平与胎儿出生体重的关系。
这项前瞻性队列研究在 2011 年 8 月至 2015 年 5 月期间在浙江舟山妇幼保健院进行。选择 1232 对单胎、足月新生儿及其无其他妊娠和围产期并发症的母亲作为参与者。
在 1232 名女性中,有 234 名患有 GDM。GDM 与出生体重呈正相关(β=99.5g,P=0.0002)、与出生体重的胎龄特异性 Z 评分呈正相关(β=0.23,P=0.0003),并且与巨大儿(OR=1.79,95%CI:1.11-2.89)和大于胎龄儿(OR=2.13,95%CI:1.34-3.40)的风险增加有关。与孕中期异常空腹血糖(FPG)相比,口服葡萄糖耐量试验中负荷后血糖异常与出生体重和胎龄特异性出生体重 Z 评分显著增加有关,且与巨大儿的风险增加有关。异常 FPG 和异常负荷后血糖对出生体重(β=161.4g,P=0.0192)、出生体重的胎龄特异性 Z 评分(β=0.42,P=0.0121)和巨大儿(OR=3.24,95%CI:1.21-8.67)和大于胎龄儿(OR=5.73,95%CI:2.20-14.90)的风险有显著的联合作用。与孕早期异常血糖相比,GDM 与出生体重和胎龄特异性出生体重 Z 评分显著增加有关。孕早期异常血糖与 GDM 对出生体重(β=125.8g,P=0.0010)、胎龄特异性出生体重 Z 评分(β=0.30,P=0.0013)和巨大儿(OR=2.34,95%CI:1.28-4.30)和大于胎龄儿(OR=2.53,95%CI:1.37-4.67)的风险有显著的联合作用。然而,我们没有发现孕早期血糖水平与出生体重有独立关系。
GDM 与较高的出生体重和较大儿及巨大儿的风险增加显著相关。胎儿生长主要受负荷后血糖水平的影响,而不是 FBG。此外,不同时间点的血糖水平对出生体重和较大儿及巨大儿的风险有显著的联合作用。